ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 247 filers reported holding ACADIA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 1.36 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,405,134 | -43.2% | 451,302 | -34.7% | 0.00% | -50.0% |
| Q2 2023 | $16,548,636 | +168591.5% | 690,966 | +32.6% | 0.01% | +50.0% |
| Q1 2023 | $9,810 | +23.2% | 521,249 | +4.2% | 0.00% | +33.3% |
| Q4 2022 | $7,961 | -99.9% | 500,077 | -46.2% | 0.00% | -50.0% |
| Q3 2022 | $15,198,000 | -1.6% | 928,973 | -15.3% | 0.01% | 0.0% |
| Q2 2022 | $15,446,000 | -31.4% | 1,096,202 | +24.3% | 0.01% | -14.3% |
| Q1 2022 | $22,532,000 | +70.6% | 881,888 | +48.4% | 0.01% | +75.0% |
| Q4 2021 | $13,211,000 | +45.0% | 594,281 | +8.9% | 0.00% | +33.3% |
| Q3 2021 | $9,113,000 | -62.1% | 545,696 | -44.7% | 0.00% | -57.1% |
| Q2 2021 | $24,061,000 | -34.7% | 986,502 | -33.4% | 0.01% | -41.7% |
| Q1 2021 | $36,869,000 | -52.7% | 1,480,487 | +1.6% | 0.01% | -53.8% |
| Q4 2020 | $77,868,000 | +19.3% | 1,456,557 | -11.4% | 0.03% | +4.0% |
| Q3 2020 | $65,272,000 | +8.8% | 1,643,479 | +32.8% | 0.02% | +4.2% |
| Q2 2020 | $59,978,000 | -29.2% | 1,237,433 | -38.3% | 0.02% | -41.5% |
| Q1 2020 | $84,743,000 | -9.8% | 2,005,744 | -8.7% | 0.04% | +13.9% |
| Q4 2019 | $93,984,000 | +68.0% | 2,196,918 | +41.3% | 0.04% | +56.5% |
| Q3 2019 | $55,950,000 | +31.8% | 1,554,597 | -2.1% | 0.02% | +35.3% |
| Q2 2019 | $42,444,000 | +4081.7% | 1,587,903 | +5476.9% | 0.02% | +240.0% |
| Q4 2015 | $1,015,000 | -3.3% | 28,473 | -10.4% | 0.01% | -16.7% |
| Q3 2015 | $1,050,000 | -22.5% | 31,765 | -1.8% | 0.01% | -14.3% |
| Q2 2015 | $1,355,000 | +24.5% | 32,355 | -27.7% | 0.01% | 0.0% |
| Q1 2014 | $1,088,000 | -10.2% | 44,723 | -7.8% | 0.01% | -12.5% |
| Q4 2013 | $1,212,000 | – | 48,520 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fairmount Funds Management LLC | 432,317 | $11,154,000 | 4.70% |
| Baker Brothers Advisors | 41,910,704 | $1,081,296,000 | 4.69% |
| Palo Alto Investors LP | 2,337,877 | $60,317,000 | 3.44% |
| Birchview Capital, LP | 177,000 | $4,567,000 | 2.71% |
| Longitude (Cayman) Ltd. | 188,000 | $4,850,000 | 1.86% |
| GREAT POINT PARTNERS LLC | 311,217 | $8,029,000 | 1.66% |
| Avoro Capital Advisors LLC | 2,500,000 | $64,500,000 | 1.11% |
| PFM Health Sciences, LP | 1,302,129 | $33,595,000 | 1.03% |
| HealthCor Management, L.P. | 900,490 | $23,233,000 | 0.82% |
| Eversept Partners, LP | 420,000 | $10,836,000 | 0.82% |